Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for weight reduction or metabolic syndrome treatment

A technology of metabolic syndrome and composition, which is applied in the direction of drug combination, metabolic disease, pharmaceutical formula, etc., and can solve the problems such as no reports of orlistat or selistat combined with rosiglitazone.

Inactive Publication Date: 2016-02-24
QINGDAO YUNTIAN BIOTECH
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there are no reports of orlistat or selistat combined with rosiglitazone at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for weight reduction or metabolic syndrome treatment
  • Pharmaceutical composition for weight reduction or metabolic syndrome treatment
  • Pharmaceutical composition for weight reduction or metabolic syndrome treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Embodiment 1: the preparation of compound tablet

[0014]

[0015] Preparation Process:

[0016] 1) Weigh orlistat, rosiglitazone hydrochloride, starch, and microcrystalline cellulose in the prescribed amount and mix uniformly;

[0017] 2) In addition, add an appropriate amount of 5% PVP ethanol solution to the mixed powder, mix evenly, make a soft material, pass through a 18-mesh sieve to make wet granules, and dry at 45°C. The moisture content of the dry granules should be controlled below 1.0%;

[0018] 3) Sorting through a 20-mesh sieve, mixing with magnesium stearate, and pressing into tablets.

Embodiment 2

[0019] Embodiment 2: the preparation of compound tablet

[0020]

[0021] Preparation Process:

[0022] 1) Weigh orlistat, rosiglitazone hydrochloride, mannitol, and microcrystalline cellulose in the prescribed amount and mix uniformly;

[0023] 2) In addition, add an appropriate amount of 5% PVP ethanol solution to the mixed powder, mix evenly, make a soft material, pass through a 18-mesh sieve to make wet granules, and dry at 50°C. The moisture content of the dry granules should be controlled below 1.0%;

[0024] 3) Sorting through a 20-mesh sieve, mixing with magnesium stearate, and pressing into tablets.

Embodiment 3

[0025] Embodiment 3: the preparation of compound tablet

[0026]

[0027]

[0028] Preparation Process:

[0029] 1) Orlistat, rosiglitazone hydrochloride, mannitol, sorbitol, and microcrystalline cellulose were weighed and mixed uniformly;

[0030] 2) In addition, add an appropriate amount of 5% PVP ethanol solution to the mixed powder, mix evenly, make a soft material, pass through a 18-mesh sieve to make wet granules, and dry at 50°C. The moisture content of the dry granules should be controlled below 1.0%;

[0031] 3) Sieve through a 20-mesh sieve, mix with magnesium palmitate stearate, and press into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for weight reduction or metabolic syndrome treatment, belongs to the field of medicine and particularly relates to a pharmaceutical composition containing orlistat or cetilistat and rosiglitazone hydrochloride, wherein the composition is of solid preparations such as common tablets, dispersible tablets, sustained release tablets, capsules and granules. An accidental discovery in experiments shows that the pharmaceutical composition containing orlistat or cetilistat and rosiglitazone hydrochloride is significantly synergistically functional in lowering blood sugar and reducing weight, a preparation method is simple, operating is convenient, and the pharmaceutical composition is suitable for industrial production.

Description

technical field [0001] The invention relates to a pharmaceutical composition for weight loss or treatment of metabolic syndrome, which belongs to the field of medicine. Background technique [0002] With the continuous improvement of living standards, changes in diet structure and transportation, people's activity level has decreased, and the obese population is increasing. There are now 7 million obese patients in my country, especially more and more adolescents are obese. There are about 30 to 40 million diabetic patients, so the incidence of patients with metabolic syndrome in our country is also very high. According to a survey conducted by the Diabetes Society of the Chinese Medical Association, the prevalence of metabolic syndrome is 14% to 16% among people over the age of 20 in urban China. Metabolic syndrome increases with age and reaches a peak in the 50-70 age group, with more women than men. Currently, there are no effective drugs on the market for the treatment...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4439A61K31/365A61K31/536A61P3/04A61P3/00
CPCA61K31/4439A61K31/365A61K31/536
Inventor 王传秀
Owner QINGDAO YUNTIAN BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com